Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-004968
Filing Date
2011-01-31
Accepted
2011-01-31 16:36:37
Documents
12
Period of Report
2010-10-31

Document Format Files

Seq Description Document Type Size
1 v209406_10k.htm 10-K 2348949
2 GRAPHIC pg10.jpg GRAPHIC 45929
3 GRAPHIC pg11a.jpg GRAPHIC 36811
4 GRAPHIC pg11b.jpg GRAPHIC 30237
5 GRAPHIC pg12.jpg GRAPHIC 44902
6 GRAPHIC pg8.jpg GRAPHIC 42096
7 GRAPHIC pg9.jpg GRAPHIC 34471
8 v209406_ex23-1.htm EX-23.1 4021
9 v209406_ex31-1.htm EX-31.1 17882
10 v209406_ex31-2.htm EX-31.2 17694
11 v209406_ex32-1.htm EX-32.1 6170
12 v209406_ex32-2.htm EX-32.2 6945
  Complete submission text file 0001144204-11-004968.txt   2727046
Mailing Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902
Business Address TECHNOLOGY CENTRE OF NEW JERSEY 675 ROUTE 1 NORTH BRUNSWICK NJ 08902 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

EIN.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-28489 | Film No.: 11559893
SIC: 2834 Pharmaceutical Preparations